Announcement

Collapse
No announcement yet.

Ibudilast clinical trial

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Ibudilast clinical trial

    There is a clinical trial admitting people with PPMS starting now at 26 different sites. Check clinicaltrials .gov for details. Good luck

    #2
    Thanks, Jerry!

    This is Phase 2 clinical trial, and is for both SPMS and PPMS.

    Purpose

    This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study designed to evaluate the safety, tolerability and activity of ibudilast administered twice daily over a 96 week period in subjects with primary or secondary progressive multiple sclerosis who are currently untreated with long-term MS disease modifying therapy (DMT) or who are receiving either glatiramer acetate (GA) or interferon beta (IFNβ-1a [Avonex, Rebif] or IFNβ-1b [Betaseron Etavia]) treatment. Study drug will be administered as an adjunct to glatiramer or beta interferon treatment.

    For more information, including criteria and study locations, here is the link:

    http://clinicaltrials.gov/ct2/show/s...ow_locs=Y#locn

    Best wishes,
    Kimba

    “When you change the way you look at things, the things you look at change.” ― Max Planck

    Comment


      #3
      I am being considered for inclusion in this trial. I was just contacted by email and informed that the trial facility ( Columbia Med Center) doesn't have firm dates at this time, but the dates are being scheduled, now. Anyone here in this trial?

      Comment

      Working...
      X